
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Are targeted therapies for diabetic cardiomyopathy on the horizon?
Mitchel Tate, David J. Grieve, Rebecca H. Ritchie
Clinical Science (2017) Vol. 131, Iss. 10, pp. 897-915
Open Access | Times Cited: 87
Mitchel Tate, David J. Grieve, Rebecca H. Ritchie
Clinical Science (2017) Vol. 131, Iss. 10, pp. 897-915
Open Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
Basic Mechanisms of Diabetic Heart Disease
Rebecca H. Ritchie, E. Dale Abel
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1501-1525
Open Access | Times Cited: 485
Rebecca H. Ritchie, E. Dale Abel
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1501-1525
Open Access | Times Cited: 485
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Thomas H. Marwick, Rebecca H. Ritchie, Jonathan E. Shaw, et al.
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 3, pp. 339-351
Open Access | Times Cited: 304
Thomas H. Marwick, Rebecca H. Ritchie, Jonathan E. Shaw, et al.
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 3, pp. 339-351
Open Access | Times Cited: 304
Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
Giulia Borghetti, Dirk von Lewinski, Deborah Eaton, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 196
Giulia Borghetti, Dirk von Lewinski, Deborah Eaton, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 196
Diabetic Cardiomyopathy
Stefania Paolillo, Fabio Marsico, Maria Prastaro, et al.
Heart Failure Clinics (2019) Vol. 15, Iss. 3, pp. 341-347
Closed Access | Times Cited: 195
Stefania Paolillo, Fabio Marsico, Maria Prastaro, et al.
Heart Failure Clinics (2019) Vol. 15, Iss. 3, pp. 341-347
Closed Access | Times Cited: 195
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Arpeeta Sharma, Mitchel Tate, Geetha Mathew, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 172
Arpeeta Sharma, Mitchel Tate, Geetha Mathew, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 172
6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway
Shenglin Wu, Jinxiu Zhu, Guihai Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 84
Shenglin Wu, Jinxiu Zhu, Guihai Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 84
Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
Charshawn Lahnwong, Nipon Chattipakorn, Nipon Chattipakorn
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 151
Charshawn Lahnwong, Nipon Chattipakorn, Nipon Chattipakorn
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 151
Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
R. J. Pickering, Carlos J. Rosado, Arpeeta Sharma, et al.
Clinical & Translational Immunology (2018) Vol. 7, Iss. 4
Open Access | Times Cited: 149
R. J. Pickering, Carlos J. Rosado, Arpeeta Sharma, et al.
Clinical & Translational Immunology (2018) Vol. 7, Iss. 4
Open Access | Times Cited: 149
Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats
Xu-Tao Wang, Yan Gong, Bin Zhou, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 1461-1467
Closed Access | Times Cited: 101
Xu-Tao Wang, Yan Gong, Bin Zhou, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 1461-1467
Closed Access | Times Cited: 101
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics
Daniel Jakubik, Alex Fitas, Ceren Eyileten, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 74
Daniel Jakubik, Alex Fitas, Ceren Eyileten, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 74
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart
Darnel Prakoso, Shiang Y. Lim, Jeffrey R. Erickson, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 1, pp. 212-225
Closed Access | Times Cited: 68
Darnel Prakoso, Shiang Y. Lim, Jeffrey R. Erickson, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 1, pp. 212-225
Closed Access | Times Cited: 68
Diabetic heart disease: A clinical update
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 4, pp. 383-406
Open Access | Times Cited: 61
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 4, pp. 383-406
Open Access | Times Cited: 61
Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway
Hongchao Wang, Lijie Wang, Fuli Hu, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 55
Hongchao Wang, Lijie Wang, Fuli Hu, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 55
Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs
Mirjana Mačvanin, Zoran Gluvić, Jelena Radovanović, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Mirjana Mačvanin, Zoran Gluvić, Jelena Radovanović, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy
Zichong Song, Jingyi Wang, Lijun Zhang
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 612-622
Open Access | Times Cited: 10
Zichong Song, Jingyi Wang, Lijun Zhang
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 612-622
Open Access | Times Cited: 10
Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis
Sijie Jin, He Wang, Xiaohao Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116457-116457
Open Access | Times Cited: 9
Sijie Jin, He Wang, Xiaohao Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116457-116457
Open Access | Times Cited: 9
Metformin attenuates ER stress–induced mitochondrial dysfunction
Qun Chen, Jeremy Thompson, Ying Hu, et al.
Translational research (2017) Vol. 190, pp. 40-50
Open Access | Times Cited: 74
Qun Chen, Jeremy Thompson, Ying Hu, et al.
Translational research (2017) Vol. 190, pp. 40-50
Open Access | Times Cited: 74
Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO‐1
Hai‐Han Liao, Jinxiu Zhu, Hong Feng, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 74
Hai‐Han Liao, Jinxiu Zhu, Hong Feng, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 74
Is autophagy associated with diabetes mellitus and its complications? A review.
Debalina Bhattacharya, Mainak Mukhopadhyay, Maitree Bhattacharyya, et al.
PubMed (2018) Vol. 17, pp. 709-720
Closed Access | Times Cited: 74
Debalina Bhattacharya, Mainak Mukhopadhyay, Maitree Bhattacharyya, et al.
PubMed (2018) Vol. 17, pp. 709-720
Closed Access | Times Cited: 74
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Qutuba G. Karwi, Kim L. Ho, Simran Pherwani, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 686-715
Open Access | Times Cited: 55
Qutuba G. Karwi, Kim L. Ho, Simran Pherwani, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 686-715
Open Access | Times Cited: 55
Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress
Mengyuan Chen, Xiangfei Meng, Yu-Peng Han, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 31
Mengyuan Chen, Xiangfei Meng, Yu-Peng Han, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 31
Single-cell analysis reveals lysyl oxidase (Lox)+ fibroblast subset involved in cardiac fibrosis of diabetic mice
Heyangzi Li, Xiaoqing Zhu, Xi Cao, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 223-237
Open Access | Times Cited: 22
Heyangzi Li, Xiaoqing Zhu, Xi Cao, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 223-237
Open Access | Times Cited: 22
A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications
Caiyan Qu, Xiyue Tan, Qichao Hu, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26863-e26863
Open Access | Times Cited: 8
Caiyan Qu, Xiyue Tan, Qichao Hu, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26863-e26863
Open Access | Times Cited: 8
Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress
Zhaohui Pei, Qinqin Deng, Sara A. Babcock, et al.
Toxicology Letters (2017) Vol. 284, pp. 10-20
Closed Access | Times Cited: 58
Zhaohui Pei, Qinqin Deng, Sara A. Babcock, et al.
Toxicology Letters (2017) Vol. 284, pp. 10-20
Closed Access | Times Cited: 58